7 active trials 2 recruiting 6 Phase 3 4 disease areas
| Phase 2 | 1 | |
| Phase 3 | 6 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT05254743 | A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic… | Chronic Lymphocytic Leukemia | Recruiting | 2026-08-17 |
| NCT04662255 | Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With… | Lymphoma, Mantle-Cell | Active, Not Recruiting | 2026-05-15 |
| NCT04666038 | Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab… | Chronic Lymphocytic Leukemia | Active, Not Recruiting | 2026-04-24 |
| NCT04211337 | A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid… | Medullary Thyroid Cancer | Active, Not Recruiting | 2026-03-19 |
| NCT04965493 | A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax… | Chronic Lymphocytic Leukemia | Active, Not Recruiting | 2026-01-29 |
| NCT05023980 | A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated… | Chronic Lymphocytic Leukemia | Active, Not Recruiting | 2026-01-22 |
| Phase 2 | ||||
| NCT06588478 | A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed… | Chronic Lymphocytic Leukemia | Recruiting | 2026-05-19 |
Chronic Lymphocytic Leukemia (CLL) (5) · Leukemia (5) · Mantle Cell Lymphoma (1) · Thyroid Cancer (1)